Herpes zoster pain, postherpetic neuralgia, and quality of life in the elderly

Pain Practice

Volumn 11, Issue 4, 2011, Pages 397-402

  Pickering, Gisèle ^a   Leplege, Alain ^b  

^a INSERM   (France)

^b CNRS Université Paris Diderot Sorbonne Paris Cité   (France)

Author keywords

Herpes zoster; Postherpetic neuralgia; Quality of life; Review

Indexed keywords

VARICELLA ZOSTER VACCINE;

AGED; AGING; CHRONIC PAIN; COPING BEHAVIOR; GERIATRIC PATIENT; HEADACHE; HEALTH STATUS; HERPES ZOSTER; HUMAN; INJECTION SITE PAIN; PHYSICAL ACTIVITY; POSTHERPETIC NEURALGIA; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; REVIEW; SHORT FORM 12; SHORT FORM 36;

EID: 79960161429     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/j.1533-2500.2010.00432.x     Document Type: Review

References (38)

1. Pickering G. Age differences in clinical pain states. In: Gibson SJ, Weiner DK, eds. Pain in Older Persons, Vol. 35. Seattle: IASP Press; 2005:67-85.
2. Torrance N, Smith BH, Bennett MI, Lee AJ. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain. 2006;7:281-289.
3. Bouhassira D, Lantéri-Minet M, Attal N, Laurent B, Touboul C. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain. 2007;136:380-387.
4. Bowsher D. Neurogenic pain syndromes and their management. Br Med Bull. 1991;47:644-666.
5. Arvin A. Aging, immunity and the Varicella-zoster virus. N Engl J Med. 2005;352:2266-2267.
6. Hope-Simpson RE. Postherpetic neuralgia. J R Coll Gen Pract. 1975;25:571-575.
7. Helgason S, Petursson G, Gudmundsson S, Sigurdsson JA. Prevalence of postherpetic neuralgia after a single episode of herpes zoster: prospective study with long term follow up. BMJ. 2000;321:794-796.
8. Ware JE, Kosinski M, Keller SD. SF-12®: How to Score the SF-12® Physical and Mental Health Summary Scales. 2nd ed. Boston, MA: The Health Institute, New England Medical Center; 1995.
9. Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36®): I. Conceptual framework and item selection. Med Care. 1992;30:473-483.
10. Chuck A, Adamowicz W, Jacobs P, Ohinmaa A, Dick B, Rashiq S. The willingness to pay for reducing pain and pain-related disability. Value Health. 2009;12:498-506.
11. Tijhuis G, Jansen S, Stiggelbout A, Zwinderman A, Hazes J, Vlieland T. Value of the time trade off method for measuring utilities in patients with rheumatoid arthritis. Ann Rheum Dis. 2000;59:892-897.
12. EuroQoL Group. EuroQoL-a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199-208.
13. Bradley C. Importance of differentiating health status from quality of life. Lancet. 2001;357:7-8.
14. Katz J, Cooper EM, Walther RR, Sweeney EW, Dworkin RH. Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis. 2004;39:342-348.
15. Coplan P, Schmader K, Nikas A, etal. Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory. J Pain. 2004;344-356.
16. Cleeland CS. Measurement and prevalence of pain in cancer. Semin Oncol Nurs. 1985;1:87-92.
17. Oster G, Harding G, Dukes E, Edelsberg J, Cleary PD. Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey. J Pain. 2005;6:356-363.
18. Schmader KE, Sloane R, Pieper C, etal. The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults. Clin J Pain. 2007;23:490-496.
19. Lydick E, Epstein RS, Himmelberger D, White CJ. Herpes zoster and quality of life: a self-limited disease with severe impact. Neurology. 1995;45(12 suppl 8):S52-S53.
20. Bennett MI, Smith BH, Torrance N, Potter J. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinic and postal research. J Pain. 2005;6:149-158.
21. Opstelten W, Zuithoff NP, van Essen GA, etal. Predicting postherpetic neuralgia in elderly primary care patients with herpes zoster: prospective prognostic study. Pain. 2007;132(suppl 1):S52-S59.
22. Schmader K. Herpes zoster in older adults. Clin Infect Dis. 2001;32:1481-1486.
23. Kauskopf J, Austin R, Dix L, Berzon R. The Nottingham Health Profile as a measure of quality of life in zoster patients: convergent and discriminant validity. Qual Life Res. 1994;3:431-435.
24. Schmader K, Gnann JW Jr, Watson CP. The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine. J Infect Dis. 2008;197(suppl 2):S207-S215.
25. Turk DC, Dworkin RH, Allen RR, etal. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain. 2003;106:337-345.
26. Volpi A, Gatti A, Pica F, Bellino S, Marsella LT, Sabato AF. Clinical and psychosocial correlates of post-herpetic neuralgia. J Med Virol. 2008;80:1646-1652.
27. Pickering G, Capriz-Ribière F. Neuropathic pain in the elderly. Psychol Neuropsychiatr Vieil. 2008;6:107-114.
28. Johnson RW, Bouhassira D, Kassianos G, Leplège A, Schmader KE, Weinke T. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med. 2010;8:37.
29. Karp JF, Reynolds CF 3rd, Butters MA, etal. The relationship between pain and mental flexibility in older adult pain clinic patients. Pain Med. 2006;7:444-452.
30. Karp JF, Rudy T, Weiner DK. Persistent pain biases item response on the Geriatric Depression Scale (GDS): preliminary evidence for validity of the GDS-PAIN. Pain Med. 2008;9:33-43.
31. Baliki MN, Geha PY, Apkarian AV, Chialvo DR. Beyond feeling: chronic pain hurts the brain, disrupting the default-mode network dynamics. J Neurosci. 2008;28:1398-1403.
32. Pickering G, Salimani R, Dubray C, Sembel N. Cognitive impact of post-herpetic neuralgia in elderly persons. Poster, NeuSIG, Athenes, Greece; 2010.
33. Gyurcsik NC, Brawley LR, Spink KS, Brittain DR, Fuller DL, Chad K. Physical activity in women with arthritis: examining perceived barriers and self-regulatory efficacy to cope. Arthritis Rheum. 2009;61:1087-1094.
34. Li Q, Chen N, Yang J, etal. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev. 2009;(2):CD006866.
35. Oxman MN, Levin MJ, Johnson GR, etal. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352:2271-2284.
36. Oxman MN, Levin MJ. Vaccination against herpes zoster and postherpetic neuralgia. J Infect Dis. 2008;197(suppl 2):S228-S236.
37. Van Hoek AJ, Gay J, Melegaro A, Opstelten W, Edmunds WJ. Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales. Vaccine. 2009;27:1454-1467.
38. Van Lier A, van Hoek AJ, Opstelten W, Boot HJ, de Melker HE. Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands. BMC Health Serv Res. 2010;10:237.